2011Journal of Henan Medical College for Staff and WorkersRequires access

Effect of Azithromycin for the Treatment of Children with Mycoplasmal Pneumonia

Zhuang Tan-yue

Open publisher page 0 citations

Abstract

Objective To investigate the effect of Azithromyci for the treatment of children with mycoplasmal pneumonia.Methods 172 children with mycoplasmal pneumonia were randomly divided into treatment group(86 cases) and Erythrocin group(86 cases).Treatment group were given Azithromycin and control group were given Erythromycin after general treatment and symptomatic treatment.The rate of clinical effect,clinical symptom extinction time,length of stay,and drug adverse reaction were compared between two groups.Results Clinical effective rate of Azithromycin group(93.02%) was significantly higher than that of Erythrocin group(81.40%)(χ2=5.212,P=0.022).Time of body temperature returned to common,cough regression,and hospital day in Azithromycin group were significantly lower than that of Erythromycin group(P0.05).The incident rates of gastrointestinal reaction and local pain were lower in Azithromycin group than that of in Erythrocin group(P0.05).Conclusion Clinical effect of treatment with Azithromycin for children with mycoplasmal pneumonia is good,and it has quickly,high performance and drug adverse reaction is safety,and merits to compliance.

About this research paper

What this paper is about

Objective To investigate the effect of Azithromyci for the treatment of children with mycoplasmal pneumonia.Methods 172 children with mycoplasmal pneumonia were randomly divided into treatment group(86 cases) and Erythrocin group(86 cases).Treatment group were given Azithromycin and control group were given Erythromycin after general treatment and symptomatic treatment.The rate of clinical effect,clinical symptom extinction time,length of stay,and drug adverse reaction were compared between two groups.Results Clinical effective rate of Azithromycin group(93.02%) was significantly higher than that of Erythrocin group(81.40%)(χ2=5.212,P=0.022).Time of body temperature returned to common,cough regression,and hospital day in Azithromycin group were significantly lower than that of Erythromycin group(P0.05).The incident rates of gastrointestinal reaction and local pain were lower in Azithromycin group than that of in Erythrocin group(P0.05).Conclusion Clinical effect of treatment with Azithromycin for children with mycoplasmal pneumonia is good,and it has quickly,high performance and drug adverse reaction is safety,and merits to compliance.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the effect of Azithromyci for the treatment of children with mycoplasmal pneumonia.Methods 172 children with mycoplasmal pneumonia were randomly divided into treatment group(86 cases) and Erythrocin group(86 cases).Treatment group were given Azithromycin and control group were given Erythromycin after general treatment and symptomatic treatment.The rate of clinical effect,clinical symptom extinction time,length of stay,and drug adverse reaction were compared between two groups.Results Clinical effective rate of Azithromycin group(93.02%) was significantly higher than that of Erythrocin group(81.40%)(χ2=5.212,P=0.022).Time of body temperature returned to common,cough regression,and hospital day in Azithromycin group were significantly lower than that of Erythromycin group(P0.05).The incident rates of gastrointestinal reaction and local pain were lower in Azithromycin group than that of in Erythrocin group(P0.05).Conclusion Clinical effect of treatment with Azithromycin for children with mycoplasmal pneumonia is good,and it has quickly,high performance and drug adverse reaction is safety,and merits to compliance.

Key concepts: Azithromycin, Medicine, Erythromycin, Pneumonia, Internal medicine, Adverse effect, Mycoplasma pneumonia, Drug reaction

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of Azithromycin for the Treatment of Children with Mycoplasmal Pneumonia — Research Paper | ScholarLens